ALYSSA OLIVER: Open Payments
NPI 1417434754 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 58 payments from 20 companies in 2025. Trend: 2023 $2,808 · 2024 $1,866 · 2025 $1,402
Food & beverage: $1,293Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $322 |
| Janssen Biotech, Inc. | 5 | $161 |
| UCB, Inc. | 5 | $152 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $111 |
| LEO Pharma Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Lilly USA, LLC | 2 | $51 |
| Organon LLC | 3 | $46 |
| GENZYME CORPORATION | 2 | $42 |
Products named: SKYRIZI, TREMFYA, Bimzelx, DAXXIFY, ILUMYA, RINVOQ, DUPIXENT, ADBRY.
Industry payments across NV — which companies pay providers there.
